Ca
Carmot (Roche)
Berkeley CAFounded 201460 employees
Private CapbiotechAcquiredMetabolic
Platform: GLP-1/GIP/GCG
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxavorutinib | CAR-9408 | NDA/BLA | 1 | TIGIT | NMOSDFabry | ||
| CAR-6194 | CAR-6194 | Preclinical | 2 | GLP-1R | AsthmaHCC |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (1)